Our Recent Publications
More Articles
CURRENT TRENDS AND AVAILABILITY OF INJECTABLE THERAPY IN PAKISTAN FOR MANAGEMENT OF DIABETES MELLITUS
Diabetes is a metabolic disorder and is a growing healthcare problem in South Asian countries. The management guidelines…
Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country
This study showed that direct costs significantly contributed to diabetes’s overall cost in Pakistan and overall diabetes management estimated to be…
Efficacy & Safety of Empagliflozin & Metformin with Sitagliptin & Metformin during Ramadan: An Observational Study. Diabetes Research and Clinical Practise DRCP
Patients of the SGLT-2i group experienced similar symptomatic hypoglycemic episodes (15.9%) as the sitagliptin group. There was an improvement in blood sugar…
Essential diagnostics and devices in primary care diabetes
Medication is essential for diabetes care, and this is reflected in the Essential Medicines lists prepared by the World Health Organization and various countries. The need for essential diagnostics…
Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients
Background and Objectives Liraglutide, an analog of human glucagon-like peptide 1 (GLP-1), has been approved for the treatment of type 2 diabetes mellitus in Pakistan since ..
The Outcomes of Dapagliflozin Use in Real-Life Clinical Settings in Endocrinology Clinics of Islamabad, Pakistan
Introduction Dapagliflozin is a member of a novel class of drugs (sodium-glucose cotransporter-2 inhibitors) used to treat type 2 diabetes mellitus and licensed in Pakistan in.
Analyze the prevalence of DPN using VPT : Age, Duration of disease, BMI, HbA1c in T2DM patients - Cross Sectional study
Diabetic peripheral neuropathy (DPN)
commonly presents as distal symmetric polyneuropathy of lower extremities, typically characterized by significant deficits in tactile sensitivity, vibration…
EFFICACY OF DAPAGLIFLOZIN AND ITS ROLE ON MICROALBUMINURIA: MULTICENTRIC REAL WORLD EVIDENCE FROM PAKISTAN
Disease progression in diabetes accompany a
surge in complications that needs to be tackled.
To achieve glycemic goals a comprehensive and
effective antidiabetic drug regimen…